November

November 28, 2013

Therapeutic targeting of mammary cancer cell invasiveness: CEBP/β increases Junctional adhesion molecule A (JAM-A) expression via down regulation of its target gene, 28/October/2013, 8.24 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Therapeutic targeting of mammary cancer cell invasiveness: CEBP/β increases Junctional adhesion molecule A (JAM-A) expression via down regulation […]
November 28, 2013

Therapeutic targeting of mammary cancer cell motility and invasiveness: RREB1 [Ras responsive element (RRE) binding protein] increases Fascin expression via down regulation of its target gene, 28/November/2013, 8.21 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Therapeutic targeting of mammary cancer cell motility and invasiveness: RREB1 [Ras responsive element (RRE) binding protein] […]
November 28, 2013

Targeting glioma cell migration: RREB1 [Ras responsive element (RRE) binding protein] increases CTGF expression via down regulation of it target gene, 28/November/2013, 8.13 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Targeting glioma cell migration: RREB1 [Ras responsive element (RRE) binding protein] increases CTGF expression via […]
November 28, 2013

Turning an anticoagulant into an anti-cancer drug: Heparin increases the expression of tumor suppressor Neurofibromin (NF1) via down regulation of its target gene, 28/November/2013, 7.57 am

Idea Proposed by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Turning an anticoagulant into an anti-cancer drug: Heparin increases the expression of tumor suppressor Neurofibromin  (NF1) […]